Document:

xlrm_ex44.htm

EXHIBIT 4.4
  
 
 Letter of Engagement 
 CMA Initials_____
 Company Initials_____
   
 January 25, 2022 
  
 Michael Hill, CEO
 Barrett Evans, President
 Bloomios, Inc.
 201 W. Montecito St.
 Santa Barbara, CA 93101
  
 RE: Engagement for Investor and public relations services.
  
 Dear Michael and Barrett:
  
 Thank you for choosing CMA as your investor and public relations representative. This Letter of Engagement sets forth and memorializes our mutual understanding and agreement (collectively the “Agreement”) between Bloomios, Inc. (the “Company”) and Capital Market Access, LLC (“CMA”) regarding Investor Relations (“IR”) and Public Relations (“PR”) advisory services (collectively the “Services”) to be rendered to the Company by CMA.
  
 This Agreement supersedes and replaces any previous agreement for Services. When countersigned by the Company and CMA (hereafter collectively referred to as the “Parties” or “Party”) in the space provided below, this letter shall serve as the Parties’ Agreement regarding the Services as follows:
  
 1. The Services
  
 The Company hereby engages CMA and CMA hereby agrees to provide the Services to the Company, which shall include but are not limited to timely response by telephone, email or regular mail or by other such means to all inquiries related to the Company from the press, shareholders, investors, analysts and other interested parties. Such response may consist of written materials, such as copies of public announcements, press kits, corporate presentations and profiles, as well as organizing investor and media teleconferences with Company management.
  
 CMA will make reasonable efforts to increase public awareness of the Company by helping to create, organize and supervise the production and dissemination of informational materials, such as Company presentations and corporate profiles, as well as perform outreach and make introductions to potential investors, analysts, capital market institutions, and members of the media.
  
 CMA will also help establish and manage third-party IR- and PR-related services on the Company’s behalf, such as newswire services, regulatory filing services and conference call vendors, and serve when requested as the Company’s IR and PR liaison and spokesperson.
  
 A further listing of the Services to be performed by CMA are incorporated by reference to the “Bloomios Capital Market Access Campaign Proposal,” dated December 30, 2021.
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 2 of 9
  
 2. CMA Non-broker Status
  
 CMA will advise the Company regarding best practices that are typical of investor relations; however, the Parties acknowledge that CMA does not hold any broker-dealer registrations and does not perform legal or investment advisory services and/or advise any person or entity to buy or sell the Company’s stock or other securities.
  
 CMA will serve only as a liaison between the Company and the public and disseminate information only as an intermediary on the Company’s behalf, and CMA undertakes no responsibility to independently corroborate or verify any such information. It is further understood that any of the Company’s offering materials would make it clear that when determining whether to invest, purchasers are relying only upon statements authorized and made by the Company, and such statements are subject to the cautionary limitations set forth in the Company’s offering materials.
  
 3. Base Compensation 
  
 In compensation for the Services, the Company agrees to pay CMA a Base Fee of Twelve Thousand Five Hundred U.S. Dollars (USD 12,500) per month for IR and PR Services.
  
 Payment of the Base Fee shall be due at the beginning of each Month and paid by the Company no later than ten (10) days following the end of the Month. CMA will send an invoice for the Base Fee and expenses at the beginning of every month. For any partial first month, CMA will issue an invoice for the pro-rata amount.
  
 At the Company’s option, payment for the Base Fee and Expenses may be provided with the monetization of Fee Shares as discussed in Section 6, below.
  
 4. Performance-Based Compensation
  
 The Company agrees to pay CMA in Shares of the Company’s common stock, adjusted for stock splits, according to the following performance schedule. At the Company’s option, such payment of Shares would be paid first from any available “Fee Shares” provided to CMA as discussed below in Section 6.
  
 Institutional Ownership: For an introduction by CMA that results in the aftermarket purchase by an individual or a firm that represents two and one-half percent (2.5%) or greater of the Company’s total common shares outstanding at the time of this Agreement, CMA earns 20,000 Shares.
  
 Trading Volume: When a 25,000, 50,000 and 100,000 three-month average daily trading volume of the Company’s common stock is achieved, CMA earns 20,000 Shares once per instance.
  
 Research Coverage: When an introduction by CMA results in the initiation of non-paid sell-side equity research coverage of the Company issued by a licensed broker dealer, CMA earns 20,000 Shares.
  
 Options: The Company shall grant CMA stock options (the “Options”) to purchase an aggregate of up to 200,000 common shares of the Company subject to the terms and conditions of an Option agreement to be entered into between the Company and CMA. The Options will have a strike price of Three U.S. Dollars per share (USD $3.00) and vest in four equal tranches on the three-, six-, ninth- and 12-month anniversary of the Effective Date of this Agreement. The options will have a life of three years with a cashless exercise option. 
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 3 of 9
  
 5. Expenses
  
 The Company will reimburse CMA for reasonable out-of-pocket expenses incurred in connection with the Services provided to the Company, including but not limited to expenses related to telecommunications; press release newswire services; webcasts; travel (including hotel, airline tickets, ground transportation, and out of pocket expenses); third-party advertising, printing, mail processing; postage and express mail; and production of related materials within thirty (30) days upon CMA submitting to the Company an invoice itemizing such expenses. Interest on any overdue balance owed to CMA by the Company shall accrue at 1.5% per month.
  
 Unless otherwise agreed and approved in writing between CMA and the Company, all such third party and out-of-pocket expenses exceeding Five Hundred Dollars (USD$500) per instance incurred by CMA in performing the Services under this Agreement and not covered by the Base Fee are subject to approval by the Company in advance (see an example expense request form as Addendum “A,” attached). The Company shall have Forty-five (45) days from the date of an invoice to contest any such charges that it believes were not approved, after which time they shall be deemed approved by the Company.
  
 6. Method of Compensation and Use of Fee Shares 
  
 The monthly Base Fees and reimbursement for Expenses may be paid to CMA in cash or with restricted shares of the Company’s common stock, hereafter referred to as “Fee Shares.” In the event the Method of Compensation involves Fee Shares, the Company will provide the Fee Shares in the name of CMA in an amount sufficient to cover projected fees and costs as contemporaneously agreed to by the Parties. The Parties agree to an initial amount of Three Hundred Thousand (300,000) Fee Shares to be issued to CMA for this purpose.
  
 The Fee Shares may be issued to CMA prior to registration in reliance on exemptions from registration provided by Section 4(2) of the U.S. Securities Act of 1933 (the “Act”), Regulation D of the Act, and applicable state securities laws. As soon as practicable, the Company may register the restricted Fee Shares by including them in an appropriate registration statement.
  
 CMA would monetize these Fee Shares to cover cash-based fees or expenses once the shares are no longer restricted, such as upon registration or per the Rule 144 holding period (i.e., six months).
  
 Such expenses could include direct and third-party expenses CMA incurs on the Company’s behalf, such as newswire services, travel, printing, conference fees, media buys, third-party advisory and consulting fees as directed by or approved by the Company. CMA may charge a 15% Agency Fee when paying for Company expenses related to third-party services, such as newswire services, advertising, web design, media buys, and outside advisors and consultants.
  
 In the event the monthly Base Fee and reimbursement of Expenses involves the monetization of Fee Shares, CMA would continue to send the Company monthly invoices. Unless objections are made to an invoice within a reasonable length of time, such as two to three weeks from receipt by the Company, sufficient Fee Shares shall be sold by CMA at the prevailing market price to satisfy the cash portion of the invoice. From time-to-time CMA may sell Fee Shares ahead of invoices generated or may delay the sale of Fee Shares in order to accommodate the selling broker or prevailing market conditions.
  
 In regard to the holding period required under SEC Rule 144 before CMA may remove any restrictive legend on the Fee Shares, the Parties agree that any restricted Fee Shares provided to CMA are intended to be fully earned by CMA upon the Effective Date of this Agreement in consideration for securing CMA’s availability to perform the Services defined in the Agreement and through the remaining term of the Agreement, and in consideration of CMA’s acceptance of restricted shares in lieu of cash or the cash equivalent in free-trading shares.
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 4 of 9
  
 In the event the Agreement is terminated earlier or the Company chooses to begin paying fully in cash earlier than the period in which CMA would have otherwise expensed or earned the dollar equivalent of the Fee Shares provided, CMA shall provide a rebate to the Company for the difference between the amounts received from selling the Fee Shares and the amount CMA would have otherwise earned at the time the Company decided to pay in cash or the Agreement terminated. The rebate shall consist of either proceeds from the sale of the Fee Shares or the Shares themselves.
  
 During the course of CMA’s engagement by the Company and at the Company’s sole discretion, the Company may issue additional Fee Shares to CMA sufficient to cover projected annual fees and costs in an amount contemporaneously agreed to by the Parties and under the same terms and conditions as enumerated above.
  
 7.a. Term of Agreement 
  
 The Initial Term of this Agreement shall commence as of the Effective Date as indicated below and continue for twelve (12) months, and automatically renew for three (3) month periods thereafter (the “Renewal Term”).
  
 The Company or CMA, at their own discretion, may terminate this Agreement at no less than thirty (30) days prior to the end of the initial Term, Renewal Term or Extension Period with written notice to the other (see below for notification contact information).
  
 Upon request by the Company, CMA shall transfer, assign and make available to the Company or its representatives all property and materials in CMA’s possession or control that belongs to the Company. This would exclude any proprietary information and materials belonging to CMA, such as CMA contact lists, proprietary software and database and related information existing prior to or generated by CMA during the term of this Agreement.
  
 7.b. Opportunity for Term Extension
  
 CMA would like the opportunity to help fund the cost of its engagement under this Agreement. For any introductions of investors made by CMA with whom the Company did not have an existing relationship, and which resulted in an investment in the Company, and in order to secure CMA’s engagement with the Company for the benefit of such investors, the Company agrees to extend the Term of the Agreement (the “Extension Period”) at the rate of one month per Two Hundred and Fifty Thousand Dollars (USD$250,000) of such investment.
  
 The Parties acknowledge that CMA will not earn any remuneration or commission as a result of such introductions, and that CMA would be required to provide the Services as outlined above in order to receive Compensation under this Agreement.
  
 In any event, the maximum of such Extension Period would be limited to 24 months, after such time the Term of the Agreement would return to automatically renewing according to Section 7.a., above.
  
 8. Reporting
  
 CMA plans to have at least tri-weekly ‘synch up’ calls with the Company to review activities, progress, new deliverables and future plans. Also, at the Company’s request, CMA can supply a written report or presentation once per calendar or fiscal quarter regarding the general activities and actions CMA has taken on behalf of the Company, such as for board of director presentations.
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 5 of 9
  
 9. Materials
  
 For the purpose of delivering the Services, the Company will furnish any supplies and materials that CMA may reasonably need regarding the Company, its management, products, financial and business status and plans. The Company represents that to the best of its knowledge any materials or intellectual property provided to CMA are original or the rights to their use are adequately secured and therefore do not infringe upon the intellectual property rights of others.
  
 10. Independent Contractor Status
  
 CMA is acting as an independent contractor, and not as an employee or partner of the Company. As such, neither party has the authority to bind the other, nor make any unauthorized representations on the behalf of the other. Company shall carry no workmen’s compensation insurance or any health or accident insurance to cover CMA. Company shall not pay any contributions to social security, unemployment insurance, Federal or state withholding taxes nor provide any other contributions or benefits that might be expected in an employer-employee relationship.
  
 11. Indemnification
  
 The terms of indemnification are pursuant to Addendum “B”, attached.
  
 12. Confidential Information
  
 CMA will use its best efforts to maintain the confidential nature of the proprietary or confidential information the Company entrusts to it through strict control of its distribution and use. Further, CMA will use its best efforts to guard against any loss to the Company through the failure of CMA or their agents to maintain the confidential nature of such information. “Proprietary” and “confidential information,” for the purpose of this Agreement shall mean any and all information supplied to CMA which is not otherwise available to the public, including information which may be considered “inside information” within the meaning of the U.S. securities laws, rules and regulations.
  
 13. General Provisions 
  
 13.1. Governing Law and Jurisdiction
  
 This Agreement shall be governed by and interpreted in accordance with the laws of the State of California. Company and CMA consent to such jurisdiction for the enforcement of this Agreement and matters pertaining to the transaction and activities contemplated herein.
  
 13.2. Dispute Resolution
  
 In the unlikely event of any dispute between the Parties related to or arising out of this Agreement, such dispute shall be resolved by means of binding arbitration in accordance with the commercial arbitration rules of the American Arbitration Association before a single arbitrator the California Code of Civil Procedure and California Evidence Code. The Parties hereby waive the right to trial by jury. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The arbitration shall be held in Orange County, California, or such other place as may be agreed upon at the time by the Parties to the arbitration. The Parties waive any objections based on the jurisdiction or venue to the proceedings set forth in this paragraph. All fees and expenses of counsel to each Party shall be initially borne by such Party but the arbitrator shall award the prevailing party reasonable costs and expenses including reasonable attorneys’ fees and expert witness fees. If any Party fails to pay its share of the fees and expenses of the arbitrator when due the other Party may request and the arbitrator shall enter an award by default against the non-paying party unless such fees are paid within ten (10) days after the Party’s request.
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 6 of 9
  
 13.3. Unenforceable Terms
  
 Any provision hereof prohibited by law or unenforceable under the law of any jurisdiction in which such provision is applicable shall adhere to such jurisdiction only be ineffective without affecting any other provision of this Agreement. To the full extent, however, that such applicable law may by waived to the end that this Agreement be deemed to be a valid and binding agreement enforceable in accordance with its terms, the Parties hereto hereby waive such applicable law knowingly and understanding the effect of such waiver.
  
 13.4. Execution in Counterparts
  
 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same agreement. Delivery of an executed signature page of the Agreement by facsimile or other electronic transmission shall be effective as delivery of a manually executed counterpart hereof.
  
 13.5 Survival
  
 Any accrued rights to payment, any remedies, and all sections of this Agreement that by their nature would survive including, without limitation, indemnification and payment amounts due, shall survive any expiration or termination of this Agreement.
  
 13.6 Waiver
  
 Failure by either party to insist upon strict and complete performance of any or all terms or conditions contained in the Agreement shall not constitute nor be construed as a waiver of that party’s right to enforce such provision or any other provision.
  
 14. Schedule of Standard Expenses
  
 In regard to the aforementioned Expenses CMA may incur on behalf of the Company, the following table sets forth (in U.S. Dollars) a schedule of the anticipated costs for certain items:
    
 	  
	 Description
	  
	  Cost

	  
	 Printing & binding of presentations, profiles, other Company materials:   
	  
	 $0.50 per page (color ink/paper)

	  
	 Third-party investor databases (i.e., IPREO, Pitchbook)
	  
	 No charge

	  
	 Long-distance calling and cellphone charges
	  
	 No charge

	  
	 In-person conference or roadshow where CMA is 
	  
	 Cost pro-rated per CMA client 

	  
	 attending as a Company representative:
	  
	 attending (travel, hotel, food, parking, conference sponsorship fee, etc.)  

   
 15. Notices
  
 Any Notice or other communication regarding this agreement shall be made in writing and be delivered personally or by a major delivery service (i.e., FedEx, UPS, etc.), or sent by email or facsimile transmission (provided acknowledgement of its receipt thereof is delivered to the sender), or sent by certified, registered or express U.S. mail, postage prepaid, with receipt confirmation to the address or addresses below:
  
 If to CMA:
  
 Capital Market Access, LLC
 25201 Paseo de Alicia. Ste #125
 Laguna Hills, CA 6 92563
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 7 of 9
 If to the Company:
  
 Bloomios, Inc.
 201 W. Montecito St.
 Santa Barbara, CA 93101
  
 Or any such address as specified by Notice hereunder.
  
 If the foregoing is agreeable, please indicate your understanding and approval by dating and signing below and returning an original copy to me.
  
 Very truly yours,
  
 CAPITAL MARKET ACCESS, LLC
  
 Signed and Agreed:                                                                                          Date: _________________
 Geoffrey C. Plank
 Managing Partner
 Capital Market Access, LLC
  
 APPROVAL & ACCEPTANCE
  
 READ AND ACCEPTED this ____ day of January 2022, with the Effective Date deemed January ___, 2022 as the date CMA began to provide Services to the Company under this Agreement.
  
 Bloomios, Inc.
 Signed: __________________________________________
 Name: ___________________________________________ Title: ____________________________
 Bloomios, Inc.
 201 W. Montecito St.
 Santa Barbara, CA 93101
  
 	
	
	

	

  
 CMA Initials_____
 Company Initials_____
  
 Page 8 of 9
  
 CMA COMMUNICATIONS FINANCIAL PUBLIC RELATIONS & COMMUNICATIONS AGREEMENT
  
 ADDENDUM “A”
  
 A copy of this Addendum may be used by the Parties to describe and approve the costs of any additional Services provided by CMA to the Company:
  
 	 Description
	 Fee/Expense Amount
	 One time or Monthly?

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

	  
	  
	  

   
 APPROVAL AND ACCEPTANCE
  
 READ AND ACCEPTED this                    day of                           20             .
  
 CAPITAL MARKET ACCESS, LLC
 Signed: ________________________________________
 Name: _________________________________________
 Title: __________________________________________
  
 APPROVAL AND ACCEPTANCE
  
 READ AND ACCEPTED this                    day of                          20             .
   
 _________________________________________________
 Company Name
  
 Signed: _______________________________________ 
 Name: ________________________________________
 Title: _________________________________________
  
 	 
	
	

	 

  
 CMA Initials_____
 Company Initials_____
  
 Page 9 of 9
  
 Addendum “B” (Indemnification)
  
 In connection with the engagement of Capital Market Access, LLC (the “Agent”) to provide services to Bloomios, Inc. (together with its affiliates and subsidiaries, the “Company”) as set forth in the Agreement between the Company and Agent (the “Agreement”), the Company agrees to indemnify and hold harmless the Agent and its sub-agents, and their affiliates and their respective directors, officers, employees, agents and controlling persons (the Agent and each such person being an “Indemnified Party”) from and against all losses, claims, damages and liabilities (or actions, including shareholder actions, in respect thereof), joint or several, to which such Indemnified Party may become subject under any applicable federal or state law, or otherwise, which are related to or result from the performance by the Agent of the services contemplated by or the engagement of the Agent pursuant to the Agreement and will promptly reimburse any Indemnified Party for all reasonable expenses (including reasonable counsel fees and expenses) as they are incurred in connection with the investigation of, preparation for or defense arising from any threatened or pending claim, whether or not such Indemnified Party is a party and whether or not such claim, action or proceeding is initiated or brought by the Company. 
  
 The Company will not be liable to any Indemnified Party under the foregoing indemnification and reimbursement provisions (i) for any settlement by an Indemnified Party effected without its prior written consent (not to be unreasonably withheld); or (ii) to the extent that any loss, claim, damage or liability is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from the Indemnified Party’s willful misconduct or recklessness. The Company also agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company or its security holders or creditors related to or arising out of the engagement of the Agent pursuant to, or the performance by the Agent of the services contemplated by, the Agreement except to the extent that any loss, claim, damage or liability is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from the Agent’s willful misconduct or recklessness. It is expressly understood that the Company’s obligation to indemnify any loss, claim, damage or liability as incurred remains in full force and effect until such time as a final, non-appealable judgment extinguishes that obligation, at which time the Company may seek recovery from Agent for reimbursement of the sums paid to satisfy the indemnification obligation.
  
 Promptly after receipt by an Indemnified Party of notice of any intention or threat to commence an action, suit or proceeding or notice of the commencement of any action, suit or proceeding, such Indemnified Party will, if a claim in respect thereof is to be made against the Company pursuant hereto, promptly notify the Company in writing of the same. Any failure or delay by an Indemnified Party to give the notice referred to in this paragraph shall not affect such Indemnified Party’s right to be indemnified hereunder, except to the extent that such failure or delay causes actual material harm to the Company, or materially prejudices its ability to defend such action, suit or proceeding on behalf of such Indemnified Party. In case any such action is brought against any Indemnified Party and such Indemnified Party notifies the Company of the commencement thereof, the Company may elect to assume the defense thereof, with counsel reasonably satisfactory to such Indemnified Party, and an Indemnified Party may employ counsel to participate in the defense of any such action provided, that the employment of such counsel shall be at the Indemnified Party’s own expense, unless (i) the employment of such counsel has been authorized in writing by the Company, (ii) the Indemnified Party has reasonably concluded (based upon advice of counsel to the Indemnified Party) that there are legal defenses available to the Indemnification Party that are not available to the Company, or that there exists a conflict or potential conflict of interest (based upon advice of counsel to the Indemnified Party) between the Indemnified Party and the Company that makes it impossible or unethical for counsel to the Company to conduct the defense of both parties (in which case the Company will not have the right to direct the defense of such action on behalf of the Indemnified Party), or (iii) the Company has not in fact employed counsel reasonably satisfactory to the Indemnified Party to assume the defense of such action within a reasonable time after receiving notice of the action, suit or proceeding, in each of which cases the reasonable fees, disbursements and other charges of such counsel will be at the expense of the Company; provided, further, that in no event shall the Company be required to pay fees and expenses for more than one firm of attorneys (and local counsel) representing Indemnified Parties.
  
 If the indemnification provided for in this Agreement is for any reason held unenforceable by an Indemnified Party, the Company agrees to contribute to the losses, claims, damages and liabilities for which such indemnification is held unenforceable (i) in such proportion as is appropriate to reflect the relative benefits to the Company, on the one hand, and the Agent on the other hand, of a Transaction whether or not a Transaction is consummated or, (ii) if (but only if) the allocation provided for in clause (i) is for any reason unenforceable, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company, on the one hand and the Agent, on the other hand, as well as any other relevant equitable considerations. The Company agrees that for the purposes of this paragraph the relative benefits to the Company and the Agent of a Transaction as contemplated shall be deemed to be in the same proportion that the total value received or contemplated to be received by the Company in connection with a Transaction bear to the fees paid or to be paid to the Agent under this Agreement.
  
 The Company agrees that without the Agent prior written consent, which shall not be unreasonably withheld, it will not settle, compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding in respect of which indemnification could be sought under the indemnification provisions of this Agreement (whether or not the Agent or any other Indemnified Party is an actual or potential party to such claim, action or proceeding), unless such settlement, compromise or consent includes an unconditional release of each Indemnified Party from all liability arising out of such claim, action or proceeding. 
  
 In the event that an Indemnified Party is required to appear as a witness in any action brought by or on behalf of or against the Company in which such Indemnified Party is not named as a defendant, the Company agrees to promptly reimburse the Agent on a monthly basis for all reasonable expenses incurred by it in connection with such Indemnified Party’s appearing and preparing to appear as such a witness, including, without limitation, the reasonable fees and disbursements of its legal counsel. If multiple claims are brought with respect to at least one of which indemnification is permitted under applicable law and provided for under this Agreement, the Company agrees that any judgment or arbitration award shall be conclusively deemed to be based on claims as to which indemnification is permitted and provided for, except to the extent the judgment or arbitration award expressly states that it, or any portion thereof, is based solely on a claim as to which indemnification is not available.xlrm_ex101.htm

EXHIBIT 10.1
  
 SECURITIES PURCHASE AGREEMENT
  
 This SECURITIES PURCHASE AGREEMENT (the ‘Agreement’), dated as of February 24, 2022, by and between BLOOMIOS, INC., a Nevada corporation, with its address at 201 W Montecito Street, Santa Barbara, California 93101 (the ‘Company’), and SIXTH STREET LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Alexandria VA 22314 (the ‘Buyer’).
  
 WHEREAS:
  
 A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the ‘SEC’) under the Securities Act of 1933, as amended (the ‘1933 Act’); and
  
 B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement, a promissory note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $172,200.00 (including $18,450.00 of Original Issue Discount) (the ‘Note’).
  
 NOW THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:
  
 1. Purchase and Sale of the Securities.
  
 a. Purchase of the Securities. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase from the Company the Securities as is set forth immediately below the Buyer’s name on the signature pages hereto.
  
 b. Form of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Securities be issued and sold to it at the Closing (as defined below) (the ‘Purchase Price’) by wire transfer of immediately available funds to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Securities, and (ii) the Company shall deliver such duly executed Note on behalf of the Company against delivery of such Purchase Price.
  
 c. Closing Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below, the date and time of the issuance and sale of the Securities pursuant to this Agreement (the ‘Closing Date’) shall be 12:00 noon, Eastern Standard Time on or about February 25, 2022, or such other mutually agreed upon time. The closing of the transactions contemplated by this Agreement (the ‘Closing’) shall occur on the Closing Date at such location as may be agreed to by the parties.
   
 	 
	
	

	 

  
 2. Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company that:
  
 a. Investment Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion of or otherwise pursuant to the Note (such shares of Common Stock being collectively referred to herein as the ‘Conversion Shares’ and, collectively with the Note, the ‘Securities’) for its own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.
  
 b. Accredited Investor Status. The Buyer is an ‘accredited investor’ as that term is defined in Rule 501(a) of Regulation D (an ‘Accredited Investor’).
  
 c. Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the Securities.
  
 d. Information. The Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer.
  
 e. Legends. The Buyer understands that the Securities have not been registered under the 1933 Act; and may bear a restrictive legend in substantially the following form:
  
 ‘THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ‘SECURITIES ACT’), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (2) THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE BUYER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY ACCEPTABLE TO THE ISSUER’S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.’
  
 	 
	2
	

	 

  
 The legend set forth above shall be removed and the Company shall issue a certificate without such legend to the Buyer of any Security upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such Buyer provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In the event that the Company does not reasonably accept the opinion of counsel that properly conforms to applicable securities laws provided by the Buyer with respect to the transfer of any Securities pursuant to an exemption from registration, such as Rule 144, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2 of the Note.
  
 f. Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.
  
 3. Representations and Warranties of the Company. The Company represents and warrants to the Buyer that:
  
 a. Organization and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted. ‘Subsidiaries’ means any corporation or other organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any equity or other ownership interest.
  
 b. Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note has been duly authorized by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required, (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized representative is the true and official representative with authority to sign this Agreement and the other documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms.
  
 c. Capitalization. As of the date hereof, the authorized common stock of the Company consists of 950,000,000 authorized shares of Common Stock, $0.00001 par value per share, of which 12,702,134 shares are issued and outstanding. All of such outstanding shares of capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. .
  
 	 
	3
	

	 

  
 d. Issuance of Shares. The Securities are duly authorized and reserved for issuance in accordance with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company and will not impose personal liability upon the Buyer thereof.
  
 e. No Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company of the transactions contemplated hereby and thereby will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries, if any, are not being conducted, and shall not be conducted so long as the Buyer owns any of the Securities, in violation of any law, ordinance or regulation of any governmental entity. ‘Material Adverse Effect’ means any material adverse effect on the business, operations, assets, financial condition or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements or instruments to be entered into in connection herewith.
  
 f. SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the ‘1934 Act’) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein as the ‘SEC Documents’). Upon written request the Company will deliver to the Buyer true and complete copies of the SEC Documents, except for such exhibits and incorporated documents. As of their respective dates or if amended, as of the dates of the amendments, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their respective dates or if amended, as of the dates of the amendments, the financial statements of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting principles, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.
  
 	 
	4
	

	 

  
 g. Absence of Certain Changes. Since September 30, 2021, except as set forth in the SEC Documents, there has been no material adverse change and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results of operations, prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.
  
 h. Absence of Litigation. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in their capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.
  
 i. No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require registration under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder approval provisions applicable to the Company or its securities.
  
 j. No Brokers. Except for JH Darbie & Co., Inc., the Company has taken no action which would give rise to any claim by any person for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.
  
 k. No Investment Company. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement will not be an ‘investment company’ required to be registered under the Investment Company Act of 1940 (an ‘Investment Company’). The Company is not controlled by an Investment Company.
  
 l. Breach of Representations and Warranties by the Company. If the Company breaches any of the material representations or warranties set forth in this Section 3 which is continuing after the applicable cure period as set forth in the Note, if any, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered an Event of default under Section 4.4 of the Note.
  
 	 
	5
	

	 

  
 4. COVENANTS.
  
 a. Best Efforts. The Company shall use its reasonable commercial efforts to satisfy timely each of the conditions described in Section 7 of this Agreement.
  
 b. Use of Proceeds. The Company shall use the proceeds for general working capital purposes.
  
 c. Expenses. At the Closing, the Company’s obligation with respect to the transactions contemplated by this Agreement is to reimburse Buyer’ expenses shall be $3,750.00 for Buyer’s legal fees and due diligence fee and the brokerage fee to JH Darbie & Co. Inc.
  
 d. Corporate Existence. So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence and shall not sell all or substantially all of the Company’s assets, except with the prior written consent of the Buyer.
  
 e. Breach of Covenants. If the Company breaches any of the material covenants set forth in this Section 4, and in addition to any other remedies available to the Buyer pursuant to this Agreement which is continuing after the applicable cure period as set forth in the Note, it will be considered an event of default under Section 4.4 of the Note.
  
 f. Failure to Comply with the 1934 Act. So long as the Buyer beneficially owns the Note, the Company shall comply with the reporting requirements of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.
  
 g. The Buyer is Not a ‘Dealer’. The Buyer and the Company hereby acknowledge and agree that the Buyer has not: (i) acted as an underwriter; (ii) acted as a market maker or specialist; (iii) acted as ‘de facto’ market maker; or (iv) conducted any other professional market activities such as providing investment advice, extending credit and lending securities in connection; and thus that the Buyer is not a ‘Dealer’ as such term is defined in the 1934 Act.
  
 	 
	6
	

	 

  
 5. Transfer Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered in the name of the Buyer or its nominee, for the shares underlying any conversion of the Note upon default of the Note (the ‘Conversion Shares’) in such amounts as specified from time to time by the Buyer to the Company upon conversion of the Note in accordance with the terms thereof (the ‘Irrevocable Transfer Agent Instructions’). In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount as such term is defined in the Note) signed by the successor transfer agent to Company and the Company. Prior to registration of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to an exemption from registration, all such certificates shall bear the restrictive legend specified in Section 2(e) of this Agreement. The Company warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5, will be given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated form) any certificate for Conversion Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when required by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when required by the Note and/or this Agreement. If the Buyer provides the Company and the Company’s transfer, at the cost of the Buyer, with an opinion of counsel in form, substance and scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of such Securities may be made without registration under the 1933 Act, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly instruct its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified by the Buyer. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled, in addition to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being required.
  
 6. Conditions to the Company’s Obligation to Sell. The obligation of the Company hereunder to issue and sell the Securities to the Buyer at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:
  
 a. The Buyer shall have executed this Agreement and delivered the same to the Company.
  
 b. The Buyer shall have delivered the Purchase Price in accordance with Section 1(b) above.
  
 c. The representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.
  
 	 
	7
	

	 

  
 d. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
  
 7. Conditions to The Buyer’s Obligation to Purchase. The obligation of the Buyer hereunder to purchase the Securities at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:
  
 a. The Company shall have executed this Agreement and delivered the same to the Buyer.
  
 b. The Company shall have delivered to the Buyer the duly executed Note, in accordance with Section 1(b) above.
  
 c. The Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Buyer, shall have been delivered to and acknowledged in writing by the Company’s Transfer Agent.
  
 d. The representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Buyer shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer including, but not limited to certificates with respect to the Board of Directors’ resolutions relating to the transactions contemplated hereby.
  
 e. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
  
 f. No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.
  
 	 
	8
	

	 

  
 8. Governing Law; Miscellaneous.
  
 a. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States District Court for the Eastern District of Virginia. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any objection or defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Company and Buyer waive trial by jury. The Buyer shall be entitled to recover from the Company its reasonable attorney's fees and costs incurred in connection with or related to any Event of Default by the Company, as defined in Article III of the Note. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement, the Note or any related document or agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
  
 b. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.
  
 c. Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this Agreement.
  
 d. Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.
  
 e. Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.
  
 	 
	9
	

	 

  
 f. Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be as set forth in the heading of this Agreement with a copy by fax only to (which copy shall not constitute notice) to Naidich Wurman LLP, 111 Great Neck Road, Suite 214, Great Neck, NY 11021, Attn: Allison Naidich, facsimile: 516-466-3555, e-mail: allison@nwlaw.com. Each party shall provide notice to the other party of any change in address.
  
 g. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any person that purchases Securities in a private transaction from the Buyer or to any of its ‘affiliates,’ as that term is defined under the 1934 Act, without the consent of the Company.
  
 h. Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.
  
 i. Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
  
 j. No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.
  
 	 
	10
	

	 

  
 k. Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required.
  
 [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]
  
 	 
	11
	

	 

  
 IN WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.
  
 	 BLOOMIOS, INC.
	
	 	 	 
	By:		
	  
	 Michael Hill
	  

	  
	Chief Executive Officer	 
	 		 
	 SIXTH STREET LENDING LLC
	 
		  
	  

	 By:
	  
	  

	  
	 Curt Kramer
	  

		 President
	  

  
 	 Aggregate Principal Amount of Note:
	  
	$	172,200.00	  

	 Original Issue Discount
	  
	$	18,450.00	  

	 Aggregate Purchase Price:
	  
	$	153,750.00	  

  
 	 
	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]